Merante S.; Colombo A.A.; Calatroni S.; Rocca B.; Boni M.; Bernasconi P.; Bonvini L.; Soverini S.; Alessandrino E.P., Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation., «BONE MARROW TRANSPLANTATION», 2009, 44, pp. 263 - 264 [Scientific article]
Palandri F; Castagnetti F; Soverini S; Poerio A; Gugliotta G; Luatti S; Amabile M; Martinelli G; Rosti G; Baccarani M., Pancreatic enzymes elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure, «HAEMATOLOGICA», 2009, 94, pp. 1758 - 1761 [Scientific article]
I. Iacobucci; A. Lonetti; C.T. Storlazzi; A. Ferrari; D. Cilloni;F. Messa; S. Chiaretti; C. Papayannidis; M. Messina; A. Vitale; E. Ottaviani; S. Soverini; A. Astolfi; L. Impera; F. Arruga; P.P. Piccaluga; S. Paolini; M. Baccarani; G. Saglio; F. Pane; R. Foà; G. Martinelli, PAX5 GENE IS FREQUENTLY REARRANGED IN A LARGE COHORT OF BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: ON BEHALF OF GIMEMA AL & MDS WP, in: s2, «HAEMATOLOGICA», 2009, 94, pp. 426 - 426 (atti di: 14th Congress of European Hematology Association, Berlin, Germany, June 4-7, 2009) [Abstract]
Iacobucci I.; Lonetti A.; Ferrari A.; Cilloni D.; Messa F.; Guadagnolo V.; Storlazzi C.T.; Chiaretti S.; Papayannidis C.; Messina M.; Vitale A.; Ottaviani E.; Soverini S.; Arruga F.; Piccaluga P.P.; Paolini S.; Saglio G.; Pane F.; Foà R.; Baccarani M.; Martinelli G., PAX5 GENE IS FREQUENTLY THE TARGET OF GENETIC ALTERATIONS IN BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS, in: S4, «HAEMATOLOGICA», 2009, 94, pp. 2 - 2 (atti di: 42° Congresso Nazionale SIE, Milano, Italy, October 18–21, 2009) [Abstract]
I. Iacobucci; C. Papayannidis; F. Paoloni; A. Lonetti; M. Muschen; M. Vignetti; D. Cilloni; S. Soverini; F. Messa; S. Paolini; S. Chiaretti; V. Guadagnuolo; P. Fazi; A. Vitale; G. Meloni; M. Gobbi; M. Malagola; G. Saglio; F. Pane; M. Baccarani; R. Foà; G. Martinelli, PAX5 Wild-Type without IKZF1 (Ikaros) Deletion Is Associated with Prolonged Disease-Free Survival and Low Rate of Cumulative Incidence of Relapse in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL): On Behalf of GIMEMA AL Working Party., in: Blood, «BLOOD», 2009, 114 (22), pp. 12 - 12 (atti di: 51th ASH Annual Meeting, New Orleans, LA, Dec. 5-8, 2009) [Abstract]
Soverini S; Gnani A; Colarossi S; Castagnetti F; Abruzzese E; Paolini S; Merante S; Orlandi E; de Matteis S; Gozzini A; Iacobucci I; Palandri F; Gugliotta G; Papayannidis C; Poerio A; Amabile M; Cilloni D; Rosti G; Baccarani M; Martinelli G., Philadelphia-positive patients who already harbour imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors., «BLOOD», 2009, 114, pp. 2168 - 2171 [Scientific article]
Castagnetti F; Palandri F; Amabile M; Testoni N; Luatti S; Soverini S; Iacobucci I; Breccia M; Rege Cambrin G; Stagno F; Specchia G; Galieni P; Iuliano F; Pane F; Saglio G; Alimena G; Martinelli G; Baccarani M; Rosti G., Results of high-dose imatinib mesylate in intermediate SOKAL risk chronic myeloid leukemia patients in early chronic phase: A phase II trial of the GIMEMA CML WP, «BLOOD», 2009, 113(15), pp. 3428 - 3434 [Scientific article]
Breccia M.; Frustaci A.M.; Cannella L.; Soverini S.; Stefanizzi C.; Federico V.; Grammatico S.; Santopietro M.; Alimena G., Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?, «CANCER CHEMOTHERAPY AND PHARMACOLOGY», 2009, 64, pp. 195 - 197 [Scientific article]
Lonetti A.; Iacobucci I.; Ferrari A.; Messina M.; Cilloni D.; Soverini S.; Chiaretti S.; Ottaviani E.; Papayannidis C.; Messa F.; Guadagnuolo V.; Salmi F.; Vitale A.; Arruga F.; Pane F.; Piccaluga P.P.; Gnani A.; Paolini S.; Saglio G.; Baccarani M.; Foà R.; Martinelli G., THE B-CELL MUTATOR ACTIVATION-INDUCED CYTIDINE DEAMINASE IS ALTERNATIVELY SPLICED IN BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIAPATIENTS, in: S4, «HAEMATOLOGICA», 2009, 94, pp. 68 - 68 (atti di: 42° Congresso Nazionale SIE, Milano, Italy, October 18–21, 2009) [Abstract]
Palandri F; Iacobucci I; Soverini S; Castagnetti F; Poerio A; Testoni N; Alimena G; Breccia M; Rege-Cambrin G; Tiribelli M; Varaldo R; Abruzzese E; Martino B; Luciano L; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G., Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response, «CLINICAL CANCER RESEARCH», 2009, 15, pp. 1059 - 1063 [Scientific article]
Jabbour E.; Soverini S., Understanding the role of mutations in therapeutic decision making for chronic myeloid leukemia., «SEMINARS IN HEMATOLOGY», 2009, 46, pp. S22 - S26 [Scientific article]
I. Iacobucci; A. Ferrarini; M. Sazzini; E. Giacomelli; A. Lonetti; M. Muschen; L. Sumerle; C. Papayannidis; S. Soverini; E. Ottaviani; S. Paolini; A. Ferrari; F. Messa; D. Cilloni; A. Vitale; F. Pane; G. Saglio; R. Foà; M. Baccarani; M. Delledonne; G. Martinelli, Whole Transcriptome Sequencing of a Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL) with "Next Generation Sequencing" Technology Revealed Novel Point Mutations Associated with Disease-Progression., in: Blood, «BLOOD», 2009, 114 (22), pp. 3074 - 3074 (atti di: 51th ASH Annual Meeting, New Orleans, LA, Dec. 5-8, 2009) [Abstract]
Iacobucci I; Lonetti A;; Ferrari A; Soverini S; Ottaviani E; Testoni N; Colarossi S; Salmi F; Gnani A; Paolini S; Piccaluga PP; Papayannidis C; Panagiota G; Cilloni D; Messa F;; Pane F; Vitale A; Chiaretti S; Saglio G; Foà R; Baccarani M; Martinelli G, ACTIVATION-INDUCED CYTIDINE DEAMINASE IS ABERRANTLY OVEREXPRESSED IN BCRABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AND PROMOTES DNA-SINGLE STRAND BREAKS, in: s2, «HAEMATOLOGICA», 2008, 93, pp. s35 - s35 (atti di: X Congresso Nazionale SIES Hematology, Bari, Italy, September 24 - 26, 2008) [Abstract]
A. Lonetti; I. Iacobucci; R. Zuntini; S. Ferrari; D. Cilloni; F. Messa; E. Ottaviani; F. Arruga; F. Salmi; S. Paolini; C. Papayannidis; P.P. Piccaluga; P. Giannoulia; S. Soverini; G. Saglio; F. Pane; A. Vitale; S. Chiaretti; R. Foà; M. Baccarani; G. Martinelli, ALTERNATIVE SPLICING OF IKAROS mRNA IS RESPONSIBLE FOR THE EXPRESSION OF DIFFERENT ABERRANT ISOFORMS IN PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) PATIENTS, in: s1, «HAEMATOLOGICA», 2008, 93, pp. 197 - 197 (atti di: 13th Congress of European Hematology Association, Copenhagen, Denmark, June 12-15, 2008) [Abstract]
Monteghirfo S.; Tosetti F.; Ambrosini C.; Stigliani S.; Pozzi S.; Frassoni F.; Fassina G.; Soverini S.; Albini A.; Ferrari N., Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation., «MOLECULAR CANCER THERAPEUTICS», 2008, 7, pp. 2692 - 2702 [Scientific article]
